Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Antimicrobial Chemotherapy
|
January 14, 2014
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group
Adrian Curran, Polyana Monteiro, Pere Domingo, et al.
Nutrients
|
July 27, 2024
The Impact of High Levels of Compensatory Exercise on Treatment Outcomes in Threshold and Subthreshold Bulimia Nervosa
Lucía Camacho-Barcia, Isabel Sánchez, Ana Ibáñez-Caparrós, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2004
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults
Esteban Ribera, Rosa M Lopez, Marjorie Diaz, et al.
Trials
|
October 29, 2014
Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial
Sara Barbeito, Patricia Vega, Sonia Ruiz de Azua, et al.
Revista Espanola De Enfermedades Digestivas
|
March 8, 2022
Diagnosis of biliary papillomatosis with a Spyglass® cholangioscope
Eduardo Junquera Alonso, Carlos Vargas González, Marina Terroba Alonso, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2012
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
Joaquin Burgos, Manuel Crespo, Vicenç Falcó, et al.
Antiviral Therapy
|
March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial
Adrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
Genes, Brain, and Behavior
|
June 24, 2020
Clock gene polygenic risk score and seasonality in major depressive disorder and bipolar disorder
Alex Ferrer, Javier Costas, Mònica Gratacos, et al.
Journal of Clinical Medicine
|
April 30, 2020
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
Adrian Curran, Anna Rull, Jordi Navarro, et al.
AIDS (London, England)
|
November 25, 2011
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy
Adrian Curran, Esteban Martinez, Maria Saumoy, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Antimicrobial Chemotherapy
|
January 14, 2014
Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group
Adrian Curran, Polyana Monteiro, Pere Domingo, et al.
Nutrients
|
July 27, 2024
The Impact of High Levels of Compensatory Exercise on Treatment Outcomes in Threshold and Subthreshold Bulimia Nervosa
Lucía Camacho-Barcia, Isabel Sánchez, Ana Ibáñez-Caparrós, et al.
Antimicrobial Agents and Chemotherapy
|
October 27, 2004
Steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected adults
Esteban Ribera, Rosa M Lopez, Marjorie Diaz, et al.
Trials
|
October 29, 2014
Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial
Sara Barbeito, Patricia Vega, Sonia Ruiz de Azua, et al.
Revista Espanola De Enfermedades Digestivas
|
March 8, 2022
Diagnosis of biliary papillomatosis with a Spyglass® cholangioscope
Eduardo Junquera Alonso, Carlos Vargas González, Marina Terroba Alonso, et al.
The Journal of Antimicrobial Chemotherapy
|
March 2, 2012
Dual therapy based on a ritonavir-boosted protease inhibitor as a novel salvage strategy for HIV-1-infected patients on a failing antiretroviral regimen
Joaquin Burgos, Manuel Crespo, Vicenç Falcó, et al.
Antiviral Therapy
|
March 1, 2012
Changes in body composition and mitochondrial DNA in HIV-1-infected patients switching to fixed-dose abacavir/lamivudine or tenofovir/emtricitabine: a substudy of the BICOMBO trial
Adrian Curran, Esteban Martinez, Daniel Podzamczer, et al.
Genes, Brain, and Behavior
|
June 24, 2020
Clock gene polygenic risk score and seasonality in major depressive disorder and bipolar disorder
Alex Ferrer, Javier Costas, Mònica Gratacos, et al.
Journal of Clinical Medicine
|
April 30, 2020
Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
Adrian Curran, Anna Rull, Jordi Navarro, et al.
AIDS (London, England)
|
November 25, 2011
Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy
Adrian Curran, Esteban Martinez, Maria Saumoy, et al.
Page
of 12